- Home
- PGHL vs MBRX Comparison
PGHL vs MBRX Comparison
Compare PGHL & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGHL
- MBRX
- Stock Information
- Founded
- PGHL 2018
- MBRX 2015
- Country
- PGHL Hong Kong
- MBRX United States
- Employees
- PGHL N/A
- MBRX N/A
- Industry
- PGHL
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- PGHL
- MBRX Health Care
- Exchange
- PGHL NYSE
- MBRX Nasdaq
- Market Cap
- PGHL 12.3M
- MBRX 11.3M
- IPO Year
- PGHL 2024
- MBRX 2016
- Fundamental
- Price
- PGHL $0.48
- MBRX $1.05
- Analyst Decision
- PGHL
- MBRX Strong Buy
- Analyst Count
- PGHL 0
- MBRX 2
- Target Price
- PGHL N/A
- MBRX $6.00
- AVG Volume (30 Days)
- PGHL 151.0K
- MBRX 279.4K
- Earning Date
- PGHL 05-21-2025
- MBRX 05-13-2025
- Dividend Yield
- PGHL N/A
- MBRX N/A
- EPS Growth
- PGHL N/A
- MBRX N/A
- EPS
- PGHL N/A
- MBRX N/A
- Revenue
- PGHL $17,166,534.00
- MBRX N/A
- Revenue This Year
- PGHL N/A
- MBRX N/A
- Revenue Next Year
- PGHL N/A
- MBRX N/A
- P/E Ratio
- PGHL $13.74
- MBRX N/A
- Revenue Growth
- PGHL 56.11
- MBRX N/A
- 52 Week Low
- PGHL $0.37
- MBRX $0.40
- 52 Week High
- PGHL $107.36
- MBRX $5.29
- Technical
- Relative Strength Index (RSI)
- PGHL N/A
- MBRX 54.08
- Support Level
- PGHL N/A
- MBRX $1.00
- Resistance Level
- PGHL N/A
- MBRX $1.09
- Average True Range (ATR)
- PGHL 0.00
- MBRX 0.07
- MACD
- PGHL 0.00
- MBRX 0.01
- Stochastic Oscillator
- PGHL 0.00
- MBRX 61.75
About PGHL PRIMEGA GROUP HOLDINGS LIMITED
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.